Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b191dcdff1b949e72501c1ace7178e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fe256f2e07b1769466465082fbd31ac http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5c3d199d39c9e72eb1d2a319ce50202 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-723 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02 |
filingDate |
2002-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebe91ab96a5a2b8d6b955265f163d080 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_279fee74b7ba8623e887c80677cf0f8b |
publicationDate |
2003-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-03026397-A2 |
titleOfInvention |
Thyrotropin releasing hormone receptor disruptions, compositions and methods relating thereto |
abstract |
The present invention relates to compositions and methods relating to the characterization and function of the TRH receptor. Specifically, the present invention provides transgenic animals comprising disruptions in a TRH receptor gene and methods of treating diseases conditions, such as diabetes related disorders, anxiety, pain and epilepsy. The present invention further relates to agents that modulate the TRH receptor and methods of screening for agents that modulate TRH receptor for the treatment of diseases and conditions such as diabetes related disorders, anxiety, pain and epilepsy. |
priorityDate |
2001-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |